U.S. CDMRP – Autism Research Program | Research Funding


Event details

Date 23.05.2022  
Category Call for proposal
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Autism Research Program (ARP) Awards. Three award programs are available:
  • The FY22 ARP Idea Development Award mechanism supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.
  • The FY22 ARP Career Development Award supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct innovative, high-impact ideas or early-phase, proof-of-principle clinical trials with the potential to have a major impact on ASD.. 

All applications for ARP funding are strongly encouraged to address at least one of the Areas of Emphasis as directed by Congress and have direct relevance to military health. The FY22 ARP Topic Areas are listed at the end of this announcement.

Funding:       Idea Development Award – max. $550’000
                        Career Development Award – max. $550’000

Duration:      Idea Development Award – 3 years
                        Career Development Award – 3 years

Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of assistant professor (or equivalent) are eligible.

How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a pre-proposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.

Pre-Application Deadline: May 23, 2022, 5:00 p.m. Eastern time (ET)
Full Application Deadline: August 18, 2022

Grants.gov Funding Opportunity Numbers:
  • Idea Development Award –  W81XWH-22-ARP-IDA
  • Career Development Award – W81XWH-22-ARP-CDA

Further information
  • To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Numbers given above
  • For questions about the eBRAP or Grants.gov platforms, contact the Research Office.

Areas of Emphasis:
  • Tests of implementation strategies to increase use of evidence-based practices
  • Assessment of novel therapeutics using valid preclinical models
  • Mechanisms of heterogeneous clinical expression of ASD
  • Environmental risk factors
  • Improve diagnosis across the life span
  • Factors promoting success in key transitions to independence for individuals living with ASD
  • Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)
  • Cultural, socioeconomic, and gender factors in diagnosis, treatment efficacy, delivery, and access to services
  • Mechanisms underlying sex differences in ASD (i.e., prevalence, biological mechanisms, phenotypic expression, core and comorbid syndrome expression and outcomes, developmental trajectories, diagnosis, and treatment response)
  • Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, and seizures)
  • Factors impacting quality of life during geographic relocation, such as military permanent change of station
  • Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions
  • Create tools and strategies to increase the speed with which evidence-based practices are deployed in community-based settings

Practical information

  • General public
  • Free


Event broadcasted in